The molecular mechanism of skeletal muscle autophagy in uremia: a study based on the FOXO3a/Nrf2 signaling pathway

Ma Juan, Guo Yinxue, Hu Maorong

PDF(4615 KB)
PDF(4615 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (08) : 986-993. DOI: 10.13406/j.cnki.cyxb.003556
Basic research

The molecular mechanism of skeletal muscle autophagy in uremia: a study based on the FOXO3a/Nrf2 signaling pathway

Author information +
History +

Abstract

Objective To explore the role of the forkhead box O3a(FOXO3a)/nuclear factor erythroid 2-related factor 2(Nrf2) signaling pathway in regulating skeletal muscle autophagy in uremia. Methods Twenty-four mice were randomly divided into sham group,chronic kidney disease(CKD) group,and CKD+AST-120(AST) group,with eight mice in each group. A CKD model was established by using the 5/6 nephrectomy method. Four weeks after nephrectomy,the mice in the CKD+AST group were fed with powder chow containing AST-120(a charcoal adsorbent for uremic toxin) for eight weeks. Autolysosomes in the gastrocnemius muscle were observed using a transmission electron microscope. C2C12 myoblasts were divided into control group,indophenol sulfate group(IS),and IS+si-FOXO3a group. The expression of FOXO3a was determined using real-time RT-PCR and Western blot. The diameter of C2C12 myotubes was measured with Giemsa staining. Results Compared with the CKD group,the CKD+AST group showed significant decreases in serum IS level and FOXO3a expression and the number of autolysosomes in the gastrocnemius tissue and significant increases in the masses of the gastrocnemius muscle,anterior tibial muscle,and soleus muscle(all P<0.05). Compared with the IS group,the IS+si-FOXO3a group showed significant reductions in the expression of FOXO3a,atrogin-1,and muscle RING-finger protein-1 in C2C12 cells as well as the autophagic flux of the cells and a significantly increased cell diameter(all P<0.05). Compared with the sham group,the CKD group showed significantly increased expression of Kelch-like ECH-associated protein 1(KEAP1) and significantly decreased Nrf2 expression in the gastrocnemius tissue(both P<0.05). AST treatment reversed the changes in these proteins in the gastrocnemius tissue of CKD mice. Si-Nrf2 reversed the inhibitory effect of FOXO3a knockdown on autophagic flux. Conclusion IS may promote skeletal muscle autophagy by continuously stimulating the FOXO3A-KEAP1-Nrf2 axis to participate in the pathogenesis of uremic sarcopenia.

Key words

forkhead box O3a / nuclear factor erythroid 2-related factor 2 / uremia / skeletal muscle / autophagy

Cite this article

Download Citations
Ma Juan , Guo Yinxue , Hu Maorong. The molecular mechanism of skeletal muscle autophagy in uremia: a study based on the FOXO3a/Nrf2 signaling pathway. Journal of Chongqing Medical University. 2024, 49(08): 986-993 https://doi.org/10.13406/j.cnki.cyxb.003556

References

1
王蕤婷,黄新忠. 慢性肾脏病肌萎缩的发病机制及诊疗进展[J]. 上海医学202245(12):862-867.
Wang RT Huang XZ. Progress in pathogenesis,diagnosis and treatment of muscular atrophy in chronic kidney disease[J]. Shanghai Med J202245(12):862-867.
2
马迎春. 慢性肾脏病患者运动康复的管理[J]. 肾脏病与透析肾移植杂志202231(4):353-354.
Ma YC. Management of implement exercise rehabilitation training in patients with chronic kidney disease[J]. Chin J Nephrol Dial Transplant202231(4):353-354.
3
Lee SM Han MY Kim SH,et al. Indoxyl Sulfate Might Play a Role in Sarcopenia,While Myostatin Is an Indicator of Muscle Mass in Patients with Chronic Kidney Disease:analysis from the RECOVERY Study[J]. Toxins202214(10):660.
4
Hou YC Liu YM Liao MT,et al. Indoxyl sulfate mediates low handgrip strength and is predictive of high hospitalization rates in patients with end-stage renal disease[J]. Front Med202310:1023383.
5
Caldiroli L Armelloni S Eskander A,et al. Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease[J]. Exp Gerontol2021147:111266.
6
Troutman AD Arroyo E Lim K,et al. Skeletal muscle complications in chronic kidney disease[J]. Curr Osteoporos Rep202220(6):410-421.
7
Kang SH Lee HA Kim M,et al. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing’s syndrome[J]. Am J Physiol Endocrinol Metab2017312(6):495-507.
8
Alcalde-Estévez E Sosa P Asenjo-Bueno A,et al. Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation,reducing myogenic differentiation,and promoting muscular fibrosis[J]. Sci Rep202111(1):512.
9
Radloff J Latic N Pfeiffenberger U,et al. A phosphate and calcium-enriched diet promotes progression of 5/6-nephrectomy-induced chronic kidney disease in C57BL/6 mice[J]. Sci Rep202111(1):14868.
10
Li LC Chen WY Chen JB,et al. The AST-120 recovers uremic toxin-induced cognitive deficit via NLRP3 inflammasome pathway in astrocytes and microglia[J]. Biomedicines20219(9):1252.
11
Fujita K Nonaka T Kutsuno R,et al. Electrochemical sensing of the secretion of indoxyl sulfate in a rat intestinal loop using a self-assembled monolayer-modified gold bead electrode[J]. Talanta2022247:123551.
12
Lu CH Yu R Zhang C,et al. Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC[J]. Cell Death Discov20228(1):221.
13
Ali T Rahman SU Hao Q,et al. Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation[J]. J Pineal Res202069(2):e12667.
14
Jin H Zhang L He J,et al. Role of FOXO3a transcription factor in the regulation of liver oxidative injury[J]. Antioxidants202211(12):2478.
15
Xia QH Huang XB Huang JR,et al. The role of autophagy in skeletal muscle diseases[J]. Front Physiol202112:638983.
16
Takkavatakarn K Phannajit J Udomkarnjananun S,et al. Association between indoxyl sulfate and dialysis initiation and cardiac outcomes in chronic kidney disease patients[J]. Int J Nephrol Renovasc Dis202215:115-126.
17
Hamza E Vallejo-Mudarra M Ouled-Haddou H,et al. Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease[J]. Cell Signal2023104:110583.
18
Lai S Muscaritoli M Andreozzi P,et al. Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy[J]. Nutrition201962:108-114.
19
Milan G Romanello V Pescatore F,et al. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy[J]. Nat Commun20156:6670.
20
Jang DE Song JB Park JW,et al. Protein kinase CK2 activates Nrf2 via autophagic degradation of Keap1 and activation of AMPK in human cancer cells[J]. BMB Rep202053(5):272-277.
21
Lu Q Zhang Y Zhao C,et al. Copper induces oxidative stress and apoptosis of hippocampal neuron via pCREB/BDNF/and Nrf2/HO-1/NQO1 pathway[J]. J Appl Toxicol202242(4):694-705.
22
Shekh-Ahmad T Eckel R Dayalan Naidu S,et al. KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy[J]. Brain2018141(5):1390-1403.

Comments

PDF(4615 KB)

Accesses

Citation

Detail

Sections
Recommended

/